We are live on
!
Find out more
Iovance Biotherapeutics
IOVA
IOVA
249 hedge funds and large institutions have $2.6B invested in Iovance Biotherapeutics in 2022 Q1 according to their latest regulatory filings, with 46 funds opening new positions, 109 increasing their positions, 66 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
458% more call options, than puts
Call options by funds: $41.7M | Put options by funds: $7.48M
65% more repeat investments, than reductions
Existing positions increased: 109 | Existing positions reduced: 66
18% more first-time investments, than exits
New positions opened: 46 | Existing positions closed: 39
1% more funds holding
Funds holding: 246 → 249 (+3)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0.16% less ownership
Funds ownership: 99.36% → 99.21% (-0.16%)
12% less capital invested
Capital invested by funds: $2.96B → $2.6B (-$366M)
Holders
249
Holders Change
+3
Holders Change %
+1.22%
% of All Funds
3.93%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
46
Increased
109
Reduced
66
Closed
39
Calls
$41.7M
Puts
$7.48M
Net Calls
+$34.2M
Net Calls Change
-$24.4M
Top Buyers
| 1 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$35M |
| 2 |
PA
Perceptive Advisors
New York
|
+$32.1M |
| 3 |
Millennium Management
New York
|
+$31.6M |
| 4 |
State Street
Boston,
Massachusetts
|
+$27.1M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$26.4M |
